Legacy Forbes SciBiz posts (1H11)
June 24, 2011
April 11, 2011: Open innovation — an emerging hope for biopharma?
April 22, 2011: How long timelines cramp pharma innovation
April 22, 2011 (companion guest post in In Vivo Blog): The golden mean: balancing innovation and execution in biopharma
April 29, 2011: Finding hope and beauty at a personalized medicine conference